Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)
Conclusion The PRAGUE-17 trial will determine if LAA occlusion is noninferior to treatment with NOAC in moderate- to high-risk AF patients.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Bleeding | Cardiac Arrhythmia | Cardiology | Cardiovascular | Heart | Ischemic Stroke | Stroke | Study | Thrombosis | Vitamins